Insider Trading Alert - MAR, EVER And VVUS Traded By Insiders

Yesterday, Aug. 2, 2016, 97 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $43.70 to $50,903,280.00.

Highlighted Stocks Traded by Insiders:

Marriott International (MAR) - FREE Research Report

Kyriakidis Argiris, who is Pres. Mgn. Director MEA at Marriott International, sold 3,000 shares at $71.49 on Aug. 2, 2016. Following this transaction, the Pres. Mgn. Director MEA owned 21,658 shares meaning that the stake was reduced by 12.17% with the 3,000-share transaction.

The shares most recently traded at $71.19, down $0.30, or 0.42% since the insider transaction. Historical insider transactions for Marriott International go as follows:

  • 4-Week # shares bought: 364
  • 4-Week # shares sold: 8,202
  • 12-Week # shares bought: 364
  • 12-Week # shares sold: 19,020
  • 24-Week # shares bought: 364
  • 24-Week # shares sold: 33,091

The average volume for Marriott International has been 3.2 million shares per day over the past 30 days. Marriott International has a market cap of $18.2 billion and is part of the services sector and leisure industry. Shares are up 6.95% year-to-date as of the close of trading on Friday.

Marriott International, Inc. operates, franchises, and licenses hotels and timeshare properties worldwide. The company operates through three segments: North American Full-Service, North American Limited-Service, and International. The stock currently has a dividend yield of 1.68%. The company has a P/E ratio of 21.3. Currently, there are 5 analysts who rate Marriott International a buy, 2 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MAR - FREE

TheStreet Quant Ratings rates Marriott International as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth and increase in net income. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Marriott International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

EverBank Financial (EVER) - FREE Research Report

Mylod Robert J Jr, who is Director at EverBank Financial, sold 5,000 shares at $17.95 on Aug. 2, 2016. Following this transaction, the Director owned 511,915 shares meaning that the stake was reduced by 0.97% with the 5,000-share transaction.

The shares most recently traded at $17.90, down $0.05, or 0.27% since the insider transaction. Historical insider transactions for EverBank Financial go as follows:

  • 4-Week # shares bought: 50,000
  • 4-Week # shares sold: 35,000
  • 12-Week # shares bought: 50,000
  • 12-Week # shares sold: 75,000
  • 24-Week # shares bought: 50,000
  • 24-Week # shares sold: 88,700

The average volume for EverBank Financial has been 637,500 shares per day over the past 30 days. EverBank Financial has a market cap of $2.3 billion and is part of the financial sector and banking industry. Shares are up 12.39% year-to-date as of the close of trading on Friday.

EverBank Financial Corp, a savings and loan holding company, provides various financial products and services to individuals and small and mid-size businesses in the United States. The company operates in three segments: Consumer Banking, Commercial Banking, and Corporate Services. The stock currently has a dividend yield of 1.33%. The company has a P/E ratio of 20.0. Currently, there are 2 analysts who rate EverBank Financial a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EVER - FREE

TheStreet Quant Ratings rates EverBank Financial as a hold. Among the primary strengths of the company is its expanding profit margins over time. At the same time, however, we also find weaknesses including deteriorating net income, disappointing return on equity and a generally disappointing performance in the stock itself. Get the full EverBank Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

VIVUS (VVUS) - FREE Research Report

Varghese Santosh T, who is Chief Medical Officer at VIVUS, sold 12,559 shares at $1.07 on Aug. 2, 2016. Following this transaction, the Chief Medical Officer owned 88,966 shares meaning that the stake was reduced by 12.37% with the 12,559-share transaction.

The shares most recently traded at $1.05, down $0.02, or 1.9% since the insider transaction. Historical insider transactions for VIVUS go as follows:

  • 4-Week # shares bought: 3,080
  • 4-Week # shares sold: 366
  • 12-Week # shares bought: 3,080
  • 12-Week # shares sold: 366
  • 24-Week # shares bought: 3,080
  • 24-Week # shares sold: 695

The average volume for VIVUS has been 679,600 shares per day over the past 30 days. VIVUS has a market cap of $110.3 million and is part of the health care sector and drugs industry. Shares are up 4.9% year-to-date as of the close of trading on Friday.

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet medical needs in the United States and the European Union. Currently, there is 1 analyst who rates VIVUS a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VVUS - FREE

TheStreet Quant Ratings rates VIVUS as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, weak operating cash flow and feeble growth in its earnings per share. Get the full VIVUS Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

Dow Posts First Gain in Nine Sessions; Oil Jumps

Dow Posts First Gain in Nine Sessions; Oil Jumps